Cytokinetics, Inc. (CYTK)
77.09
+0.25
(+0.33%)
USD |
NASDAQ |
Aug 24, 16:00
77.09
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics Debt to Equity Ratio : -7.324 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.324 |
| March 31, 2026 | -1.559 |
| December 31, 2025 | -1.947 |
| September 30, 2025 | -2.297 |
| June 30, 2025 | -2.327 |
| March 31, 2025 | -2.969 |
| December 31, 2024 | -5.826 |
| September 30, 2024 | -56.76 |
| June 30, 2024 | 7.279 |
| March 31, 2024 | -1.906 |
| December 31, 2023 | -1.956 |
| September 30, 2023 | -1.706 |
| June 30, 2023 | -2.249 |
| March 31, 2023 | -3.276 |
| December 31, 2022 | -6.945 |
| September 30, 2022 | -46.39 |
| June 30, 2022 | 2.931 |
| March 31, 2022 | 2.791 |
| December 31, 2021 | 1.107 |
| September 30, 2021 | 0.9632 |
| June 30, 2021 | 14.35 |
| March 31, 2021 | 3.365 |
| December 31, 2020 | 1.222 |
| September 30, 2020 | 0.9222 |
| June 30, 2020 | -1.768 |
| Date | Value |
|---|---|
| March 31, 2020 | -3.010 |
| December 31, 2019 | -12.44 |
| September 30, 2019 | -9.579 |
| June 30, 2019 | -37.93 |
| March 31, 2019 | 53.28 |
| December 31, 2018 | 1.635 |
| September 30, 2018 | 3.066 |
| June 30, 2018 | 1.936 |
| March 31, 2018 | 1.413 |
| December 31, 2017 | 0.2893 |
| September 30, 2017 | 0.8901 |
| June 30, 2017 | 0.7247 |
| March 31, 2017 | 1.289 |
| December 31, 2016 | 0.3167 |
| September 30, 2016 | 0.351 |
| June 30, 2016 | 0.6073 |
| March 31, 2016 | 0.5089 |
| December 31, 2015 | 0.2134 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Krystal Biotech, Inc. | 0.0065 |
| Ionis Pharmaceuticals, Inc. | 4.978 |
| Bristol Myers Squibb Co. | 2.019 |
| Gilead Sciences, Inc. | 2.219 |
| Rigel Pharmaceuticals, Inc. | 0.0939 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.925B |
| Total Liabilities (Quarterly) | 2.098B |
| Shareholders Equity (Quarterly) | -173.49M |
| Current Ratio | 6.661 |
| Net Debt Paydown Yield | -0.81% |